Fecal transplant cures man's melanoma: his story.

Jamie Rettinger, who was diagnosed with melanoma, underwent a fecal transplant (FMT) as part of a clinical trial at the UPMC Hillman Cancer Center in Pittsburgh. The trial aimed to improve the cure rate of patients who did not respond to immunotherapies for melanoma. The FMT engrafted and the once-missing bacteria were thriving in his gut, and his body responded to another monoclonal antibody, and signs of melanoma began to shrink. Six of 15 patients responded positively in the pilot clinical trial.